Obama''s inversion curbs kill Pfizer''s $160 bln Allergan deal

U.S. drug maker Pfizer Inc agreed on Tuesday to terminate its $160 billion agreement to acquire Botox maker Allergan Plc, in a major victory to U.S. President Barack Obama`s drive to stop tax-dodging corporate mergers.